This profile has not been claimed and data may not be accurate.
0th percentile
91st percentile
Investor Matrix
Credibility
Exits & Outcomes · 96th percentile
- Susa Ventures portfolio includes Robinhood (IPO) and Flexport, representing at least one portfolio IPO.
- Susa Ventures portfolio includes Robinhood, which reached a valuation exceeding $1B (unicorn) prior to its IPO.
Founder score
- 65%Probability of being accurate (65%)Identified researcher with an h-index of 3 and 225 citations across 3 works in areas including Acute Ischemic Stroke Management (OpenAlex).
Investor score
- 92%Probability of being accurate (92%)Partner at Susa Ventures, a recognized early-stage VC firm with a public deal record.
- 90%Probability of being accurate (90%)Active GP and fund manager at Susa Ventures, co-launching Fund V at $175M for seed-stage founders.
- 72%Probability of being accurate (72%)Susa Ventures portfolio includes Robinhood, which reached a valuation exceeding $1B (unicorn) prior to its IPO.
- 70%Probability of being accurate (70%)Approximately 14 years of investing and operating experience, starting from his healthcare and operator roles around 2011 through his current Partner role at Susa Ventures.
- 68%Probability of being accurate (68%)Susa Ventures portfolio includes Robinhood (IPO) and Flexport, representing at least one portfolio IPO.
What you likely need
Derick is a seasoned healthcare and tech investor operating as a Partner at Susa Ventures, with deep domain expertise in AI/ML and healthcare. His profile is primarily that of an institutional investor at a recognized seed-stage firm, with a strong medical and operational background that differentiates him in deal sourcing. His next leverage points are likely around deepening his public thought-leadership profile and expanding his network of founders in his core thesis areas.
Are these your current priorities?
We will tune and customize your Founder Festival experience to make sure you get invited to the events that would be most valuable to you.
- positioningPublish a structured investment thesis on AI in healthcare (e.g., a Substack or Medium post) to attract inbound deal flow from founders building in your core focus areas like AI-driven diagnostics and care coordination.
- tacticalLeverage your clinical MD background to provide hands-on regulatory and clinical-validation guidance to Susa portfolio companies like Nourish and Superpower, deepening your value-add beyond capital.
- introsTap your Stanford MBA and Harvard MD alumni networks to source pre-seed founders building at the intersection of AI and clinical workflows, where your dual expertise is a rare differentiator.
- fundraisingWith Susa Fund V at $175M freshly launched, prioritize building a systematic pipeline for pre-seed AI/ML and healthcare deals to deploy capital efficiently in the first 18 months of the fund.
- positioningPursue speaking slots at healthcare AI conferences (e.g., HLTH, Rock Health Summit) to raise your profile as a physician-investor and attract founders who want a partner who understands clinical realities.
- positioningYour published research in stroke and cerebrovascular disease (OpenAlex) is an underutilized credibility signal — consider referencing it in your public bio to reinforce your clinical depth to founders and LPs.
- introsBuild a structured operator-to-investor referral network drawing on your Viz.ai growth and BD experience, as former colleagues at AI health companies are prime sources of warm founder introductions.